FUTIBATINIB

Delivery:
oral
Indication:
breast cancer with fibroblast growth factor receptor 1/2 amplification
Locations:
US EU JP

Fibroblast growth factor receptor (FGFR) 1-4 inhibitor

Link to clinicaltrials.gov